A nurse is caring for a client who has a new prescription for atenolol. For which of the following adverse effects should the nurse monitor the client?

a. Bradycardia: Atenolol is a beta-blocker that can slow down the heart rate, leading to

bradycardia. Monitoring the client for signs of bradycardia, such as dizziness, fatigue, or fainting, is important.

b. Anemia: Atenolol is not known to cause anemia. Monitoring for anemia is not a specific concern with this medication.

c. Hypokalemia: Atenolol is not associated with causing hypokalemia. However, beta-blockers in general may affect potassium levels indirectly.

d. Neutropenia: Atenolol is not typically associated with causing neutropenia. Monitoring for neutropenia is not a specific concern with this medication.

a. Type A: Type A blood may not be compatible with the client's blood type, and it is not considered a universal donor.

b. Type B: Similar to Type A, Type B blood may not be compatible with the client's blood type, and it is not considered a universal donor.

c. Type O: Type O negative blood is considered the universal donor for packed red blood cells. It can be administered to individuals with any blood type in an emergency situation.

d. Type AB: While Type AB is considered the universal recipient for blood transfusions, it is not the universal donor.